Document is current

Article History

Received: 2 August 2025

Accepted: 8 September 2025

First Online: 16 October 2025

Declarations

:

: The protocol was approved by the institutional committee for ethical revision of medical research (IRB-CRRM) of the "G D’Annunzio" University of Chieti (protocol n: CRRM _2024_03_05_01)Written, informed consent for use of collected data for publications at the Headache Center of the "G D’Annunzio" University of Chieti is provided by patients at the start of their first visit at the Center and remains available in the personal patient chart at the Center

: UW serves on the External Consultant Board for the “NIH Preclinical Screening Platform for Pain” at the National Institutes of Health (NIH/NINDS). In her capacity as a special government employee of the US Food and Drug Administration (FDA), she has served as a voting member of the FDA Anesthetic and Analgesic Drug Products Advisory Committee. She serves as an elected member on the Council of International Association for the Study of Pain (IASP). In the past 3 years she has received compensation for serving on advisory boards or for consulting activities for Aphrodite Health Inc., Wilmington, DE, USA; Avenue Therapeutics Inc., New York, NY, USA; Bayer Aktiengesellschaft, Leverkusen, Germany; Biohaven Pharmaceuticals, New Haven, CT, USA; Hillhurst Biopharmaceuticals, Montrose, CA, USA; Seikagaku Corporation, Tokyo, Japan and Syneos Health, Morrisville, NC, USA, all unrelated to the submitted work. RO reports personal fees or non-financial support from AbbVie, Bayer, Eli Lilly, Lundbeck, Novartis, Organon, Pfizer, and Teva. All the other authors have no conflicts of interest.